[1]
“Including adolescents of childbearing potential in clinical trials with possible exposure to teratogenic medication: a challenge for paediatricians and researchers”, Swiss Med Wkly, vol. 150, no. 3940, p. w20333, Sep. 2020, doi: 10.4414/smw.2020.20333.